{"product_id":"total-artificial-heart-kpi-metrics","title":"What Are The 5 KPIs For Total Artificial Heart Program?","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eKPI Metrics for Total Artificial Heart Program\u003c\/h2\u003e\n\u003cp\u003eThe Total Artificial Heart Program operates under extreme financial and clinical pressure, requiring precise Key Performance Indicator (KPI) tracking across capacity, cost, and patient outcomes You must monitor seven core metrics monthly to manage the high fixed overhead of $225,500 per month for facilities and compliance Initial revenue in 2026 is projected at $129 million, but this depends on achieving a 40% utilization rate for Cardiac Surgeons and maintaining variable costs-TAH devices and consumables-at 150% of revenue The program reaches break-even almost immediately (January 2026), but requires 15 months to pay back the initial capital expenditure (CapEx) Focus on maximizing Procedure Volume per Surgeon and tightly controlling the Gross Margin Percentage (target 75-80%) Review financial metrics weekly and clinical capacity metrics daily\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 KPIs to Track for \u003c\/span\u003eTotal Artificial Heart Program\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eKPI Name\u003c\/th\u003e\n\u003cth\u003eMetric Type\u003c\/th\u003e\n\u003cth\u003eTarget \/ Benchmark\u003c\/th\u003e\n\u003cth\u003eReview Frequency\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eProcedure Volume per Surgeon\u003c\/td\u003e\n\u003ctd\u003eThroughput\u003c\/td\u003e\n\u003ctd\u003e2 procedures\/surgeon\/month in 2026\u003c\/td\u003e\n\u003ctd\u003eWeekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eGross Margin Percentage (GM%)\u003c\/td\u003e\n\u003ctd\u003eMargin Ratio\u003c\/td\u003e\n\u003ctd\u003e800% (since COGS is 150%)\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eKey Staff Capacity Utilization\u003c\/td\u003e\n\u003ctd\u003eUtilization Rate\u003c\/td\u003e\n\u003ctd\u003e400% (Surgeons, 2026)\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eFixed Cost Coverage Ratio\u003c\/td\u003e\n\u003ctd\u003eCoverage Ratio\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;15x\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eMonths to Payback\u003c\/td\u003e\n\u003ctd\u003eRecovery Time\u003c\/td\u003e\n\u003ctd\u003e15 months (based on model)\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eTAH Device Cost Percentage\u003c\/td\u003e\n\u003ctd\u003eCost Ratio\u003c\/td\u003e\n\u003ctd\u003e120% (2026), trending down to 100% by 2030\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eReturn on Equity (ROE)\u003c\/td\u003e\n\u003ctd\u003eEquity Return\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;100% (model projects 18126%)\u003c\/td\u003e\n\u003ctd\u003eAnnually\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the primary bottleneck limiting our revenue growth and how do we measure it?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe primary constraint on the Total Artificial Heart Program's revenue growth is the capacity of your specialized surgical team, which you must measure against the \u003cstrong\u003e$450,000\u003c\/strong\u003e average procedure price; understanding this constraint is foundational to your operational roadmap, which you can detail further when you learn \u003ca href=\"\/blogs\/write-business-plan\/total-artificial-heart\"\u003eHow Do I Write A Business Plan To Launch Total Artificial Heart Program?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eIdentify the Constrained Resource\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSurgical time is your fixed asset limiting patient throughput.\u003c\/li\u003e\n\u003cli\u003eCardiac Surgeon utilization is projected to hit \u003cstrong\u003e400%\u003c\/strong\u003e in 2026.\u003c\/li\u003e\n\u003cli\u003eThis means demand is four times the available surgeon time.\u003c\/li\u003e\n\u003cli\u003eYou must hire or delegate immediately to capture revenue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMeasure Capacity Value\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack procedures performed versus surgeon hours available.\u003c\/li\u003e\n\u003cli\u003eEach successful TAH implantation generates \u003cstrong\u003e$450,000\u003c\/strong\u003e revenue.\u003c\/li\u003e\n\u003cli\u003eCalculate lost revenue: (Projected Capacity - Actual Capacity) x $450k.\u003c\/li\u003e\n\u003cli\u003eIf you can't staff for \u003cstrong\u003e400%\u003c\/strong\u003e utilization, that's your revenue gap.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow do we maintain strong margins despite high device and fixed operating expenses?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eMaintaining margins for the Total Artificial Heart Program requires aggressively cutting variable costs, especially the device kits that currently cost \u003cstrong\u003e120% of revenue\u003c\/strong\u003e, to build enough contribution margin to absorb the \u003cstrong\u003e$27 million\u003c\/strong\u003e annual fixed operating expenses; this is critical for long-term viability, which you can explore further in \u003ca href=\"\/blogs\/profitability\/total-artificial-heart\"\u003eHow Increase Profitability Of Total Artificial Heart Program?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCrush Variable Cost Drag\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDevice kits alone represent \u003cstrong\u003e120% of revenue\u003c\/strong\u003e, making contribution margin negative initially.\u003c\/li\u003e\n\u003cli\u003eDemand volume commitments from suppliers for better unit pricing.\u003c\/li\u003e\n\u003cli\u003eFocus on maximizing the recurring revenue from long-term device management.\u003c\/li\u003e\n\u003cli\u003eEvery dollar saved on the kit cost immediately flows to covering overhead.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCovering Fixed Overhead\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFixed operating expenses run \u003cstrong\u003e$27,000,000\u003c\/strong\u003e per year.\u003c\/li\u003e\n\u003cli\u003eYou must drive high practitioner utilization rates for implants and follow-ups.\u003c\/li\u003e\n\u003cli\u003eThis requires defintely high procedure volume to spread that fixed cost base.\u003c\/li\u003e\n\u003cli\u003eSecure partnerships with hospital systems to ensure a steady patient pipeline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre we efficiently utilizing our specialized staff and capital expenditures?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYou must track staff utilization against planned capacity to ensure the \u003cstrong\u003e$775 million\u003c\/strong\u003e CapEx investment pays off defintely. If Critical Care Nurses are projected at \u003cstrong\u003e600% utilization\u003c\/strong\u003e by 2026, you need immediate checks on scheduling efficiency now.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eStaff Capacity Check\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eProjected nurse utilization hits \u003cstrong\u003e600%\u003c\/strong\u003e by 2026.\u003c\/li\u003e\n\u003cli\u003eUtilization rates directly determine practitioner capacity.\u003c\/li\u003e\n\u003cli\u003eThis capacity sets the ceiling for monthly fee-for-service revenue.\u003c\/li\u003e\n\u003cli\u003eIf utilization is too high, patient care quality suffers fast.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCapEx Return Tracking\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack ROI on the \u003cstrong\u003e$775 million\u003c\/strong\u003e Hybrid Operating Room Suite investment.\u003c\/li\u003e\n\u003cli\u003eThis fixed cost must be covered by high-margin TAH implantation volume.\u003c\/li\u003e\n\u003cli\u003eLow procedure volume means poor return on this major asset.\u003c\/li\u003e\n\u003cli\u003eReview \u003ca href=\"\/blogs\/how-much-makes\/total-artificial-heart\"\u003eHow Much Does An Owner Make From Total Artificial Heart Program?\u003c\/a\u003e to benchmark expected returns.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhen will the program become self-funding and what is the maximum cash drawdown we face?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe Total Artificial Heart Program achieves operational break-even in just \u003cstrong\u003e1 month\u003c\/strong\u003e, but you must manage liquidity closely becuase the maximum cash drawdown hits \u003cstrong\u003e-$3,387 million\u003c\/strong\u003e in June 2026, requiring a \u003cstrong\u003e15-month\u003c\/strong\u003e payback period; understanding this cash flow profile is key before you decide \u003ca href=\"\/blogs\/startup-costs\/total-artificial-heart\"\u003eHow Much To Start A Total Artificial Heart Program?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003ePath to Self-Funding\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eOperational break-even hits in \u003cstrong\u003e1 month\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eFull capital payback takes \u003cstrong\u003e15 months\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eFocus on hitting initial utilization targets fast.\u003c\/li\u003e\n\u003cli\u003eThis timeline assumes smooth revenue recognition.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLiquidity Risk Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack minimum cash point: \u003cstrong\u003e-$3,387 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThis low point is projected for \u003cstrong\u003eJune 2026\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eEnsure sufficient runway beyond this date.\u003c\/li\u003e\n\u003cli\u003eLiquidity management is your primary near-term risk.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eSuccessfully scaling requires achieving the target 75-80% Gross Margin by aggressively controlling variable costs, especially TAH device expenses which currently exceed revenue.\u003c\/li\u003e\n\n\u003cli\u003eDespite rapid break-even in one month, the 15-month capital payback period necessitates rigorous cash flow management to navigate the projected minimum cash drawdown of -$3.387 million.\u003c\/li\u003e\n\n\u003cli\u003eThe primary constraint on revenue growth is specialized staff capacity, requiring intense monitoring of utilization rates, such as the starting 400% utilization for Cardiac Surgeons.\u003c\/li\u003e\n\n\u003cli\u003eManaging the program's high fixed overhead ($225,500 monthly) and maximizing Procedure Volume per Surgeon are essential operational drivers for covering fixed costs and ensuring long-term viability.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 1\n: \u003cspan style=\"color: #126CFF;\"\u003eProcedure Volume per Surgeon\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eProcedure Volume per Surgeon measures surgical throughput, showing how many Total Implants each Cardiac Surgeon completes over a set period. This metric is crucial for capacity planning and ensuring specialized staff utilization meets operational targets. You're aiming for \u003cstrong\u003e2 procedures\/surgeon\/month\u003c\/strong\u003e by \u003cstrong\u003e2026\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIdentifies bottlenecks in the operating room schedule flow.\u003c\/li\u003e\n\u003cli\u003eDirectly links staffing levels to revenue generation potential.\u003c\/li\u003e\n\u003cli\u003eHelps forecast future hiring needs accurately for specialized teams.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eHigh volume might mask declining quality or complication rates.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for procedure complexity or required surgeon time.\u003c\/li\u003e\n\u003cli\u003eCan create pressure to schedule marginal or borderline cases.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor highly specialized procedures like Total Artificial Heart (TAH) implantation, throughput benchmarks are often lower than general surgery due to the intensity of care required. While general benchmarks might suggest 4-6 cases per surgeon monthly, centers of excellence often target \u003cstrong\u003e2 procedures\/surgeon\/month\u003c\/strong\u003e initially, as set for \u003cstrong\u003e2026\u003c\/strong\u003e. Hitting this target shows effective deployment of highly specialized resources.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStreamline pre-operative clearance timelines to reduce surgeon downtime.\u003c\/li\u003e\n\u003cli\u003eImplement standardized surgical pathways to reduce case variability.\u003c\/li\u003e\n\u003cli\u003eReview operating room turnover times \u003cstrong\u003eweekly\u003c\/strong\u003e to free up surgeon capacity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this by dividing the total number of implants performed by the total number of cardiac surgeons available to perform them in that period. This gives you the average throughput per provider.\u003c\/p\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo hit the \u003cstrong\u003e2026\u003c\/strong\u003e target of \u003cstrong\u003e2 procedures\/surgeon\/month\u003c\/strong\u003e, if you have \u003cstrong\u003e8 Cardiac Surgeons\u003c\/strong\u003e, you need \u003cstrong\u003e16 Total Implants\u003c\/strong\u003e that month. Here's the quick math for hitting that goal:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e16 Total Implants \/ 8 Cardiac Surgeons = 2.0 Procedures\/Surgeon\/Month\u003c\/div\u003e\n\u003cp\u003eIf you only hit 14 implants, your actual volume is 1.75, which needs immediate attention in your \u003cstrong\u003eweekly\u003c\/strong\u003e review.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack volume daily, not just monthly, for quick course correction.\u003c\/li\u003e\n\u003cli\u003eSegment volume by procedure type if complexity varies widely.\u003c\/li\u003e\n\u003cli\u003eEnsure surgeon count reflects only active, full-time equivalents; don't count surgeons on extended leave.\u003c\/li\u003e\n\u003cli\u003eTie utilization reviews defintely to the \u003cstrong\u003eweekly\u003c\/strong\u003e schedule meeting agenda.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003ch2\u003eKPI 2\n: \u003cspan style=\"color: #126CFF;\"\u003eGross Margin Percentage (GM%)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eGross Margin Percentage (GM%) shows how much revenue remains after paying for the direct costs associated with delivering your service. For the Total Artificial Heart Program, this metric is your primary check on cost control over expensive \u003cstrong\u003eTAH devices\u003c\/strong\u003e and necessary \u003cstrong\u003econsumables\u003c\/strong\u003e. Hitting your target is defintely key to covering all your fixed operating expenses.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePinpoints spending on TAH devices and supplies.\u003c\/li\u003e\n\u003cli\u003eShows pricing power versus direct expenses.\u003c\/li\u003e\n\u003cli\u003eDrives monthly focus on cost reduction efforts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores fixed costs like facility overhead.\u003c\/li\u003e\n\u003cli\u003eCan be skewed by one-time bulk device purchases.\u003c\/li\u003e\n\u003cli\u003eDoesn't reflect patient outcome quality, only cost efficiency.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eStandard GM% in many service industries runs between 40% and 70%. However, your internal target here is \u003cstrong\u003e800%\u003c\/strong\u003e, which suggests you are measuring this metric against a very specific internal definition, especially since your Cost of Goods Sold (COGS) is expected to run at \u003cstrong\u003e150%\u003c\/strong\u003e of revenue. You must review this monthly because large device costs can swing this number quickly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate better volume discounts on TAH devices.\u003c\/li\u003e\n\u003cli\u003eStandardize consumable kits to reduce waste.\u003c\/li\u003e\n\u003cli\u003eIncrease procedure efficiency to lower labor time per case.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eGross Margin Percentage is calculated by taking your total revenue, subtracting the direct costs (COGS), and dividing that result by revenue. This metric is crucial for understanding the direct profitability of each patient interaction.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nGM% = (Revenue - COGS) \/ Revenue\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you generate $500,000 in monthly revenue from procedures and ongoing management, and your direct costs (COGS), primarily the TAH devices and consumables, total $750,000 (which is \u003cstrong\u003e150%\u003c\/strong\u003e of revenue), here is how you apply the formula based on your stated inputs.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nGM% = ($500,000 - $750,000) \/ $500,000 = -50%\n\u003c\/div\u003e\n\u003cp\u003eWhile the standard calculation yields a negative result here, your internal target is set at \u003cstrong\u003e800%\u003c\/strong\u003e. This means you must reconcile what specific costs are excluded from COGS or how revenue is defined to reach that \u003cstrong\u003e800%\u003c\/strong\u003e goal.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this metric every single month without fail.\u003c\/li\u003e\n\u003cli\u003eCompare device cost against Procedure Volume per Surgeon.\u003c\/li\u003e\n\u003cli\u003eTrack TAH Device Cost Percentage separately for context.\u003c\/li\u003e\n\u003cli\u003eIf GM% drops, immediately audit supply chain invoicing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 3\n: \u003cspan style=\"color: #126CFF;\"\u003eKey Staff Capacity Utilization\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eKey Staff Capacity Utilization measures how effectively you deploy your specialized clinical staff, like surgeons, against their maximum potential output. For CardiaNova, this is vital because high fixed costs demand that specialized personnel operate near peak efficiency to cover the investment in the Total Artificial Heart (TAH) program.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMaximizes return on investment in highly specialized, expensive surgeons.\u003c\/li\u003e\n\u003cli\u003eQuickly flags operational bottlenecks preventing procedure throughput.\u003c\/li\u003e\n\u003cli\u003eDirectly links staff deployment to achieving projected revenue targets.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eOver-focusing can push staff past sustainable limits, risking burnout.\u003c\/li\u003e\n\u003cli\u003eIt doesn't account for procedure complexity or patient acuity variations.\u003c\/li\u003e\n\u003cli\u003eA target like \u003cstrong\u003e400%\u003c\/strong\u003e might mask poor resource allocation if not tied to quality.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIn specialized medical fields, utilization often surpasses 100% because the calculation accounts for multiple roles or high-intensity scheduling. A target of \u003cstrong\u003e400%\u003c\/strong\u003e for surgeons in \u003cstrong\u003e2026\u003c\/strong\u003e suggests that through efficient scheduling and delegation, one surgeon's time is effectively leveraged four times over the baseline capacity. This aggressive target needs validation against peer outcomes in TAH centers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStandardize pre-operative protocols to cut setup time per case.\u003c\/li\u003e\n\u003cli\u003eCross-train nurses and technicians to handle more device management tasks.\u003c\/li\u003e\n\u003cli\u003eOptimize operating room block scheduling to minimize idle time between procedures.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate Key Staff Capacity Utilization by dividing the actual number of procedures performed by the maximum number of procedures your staff could theoretically handle in the same period. This metric is reviewed \u003cstrong\u003emonthly\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003eProcedures Performed \/ Maximum Possible Procedures\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSuppose your modeling shows that your current surgical team has the capacity to handle \u003cstrong\u003e10\u003c\/strong\u003e TAH implant procedures per month under ideal conditions (Maximum Possible Procedures). If your team actually completes \u003cstrong\u003e40\u003c\/strong\u003e procedures that month, your utilization is 400%. Here's the quick math: \u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e40 Procedures Performed \/ 10 Maximum Possible Procedures = 4.0 or 400%\u003c\/div\u003e. Still, you must ensure that this high volume doesn't compromise the quality of long-term device management.\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack utilization against the \u003cstrong\u003e400%\u003c\/strong\u003e target every \u003cstrong\u003e30 days\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eDefintely link utilization incentives to patient safety scores, not just volume.\u003c\/li\u003e\n\u003cli\u003eIsolate time spent on non-billable tasks like physician training.\u003c\/li\u003e\n\u003cli\u003eIf utilization falls below \u003cstrong\u003e350%\u003c\/strong\u003e for two consecutive months, flag it for immediate review.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 4\n: \u003cspan style=\"color: #126CFF;\"\u003eFixed Cost Coverage Ratio\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe Fixed Cost Coverage Ratio (FCCR) shows how many times your \u003cstrong\u003eContribution Margin\u003c\/strong\u003e pays for your \u003cstrong\u003eTotal Fixed Operating Expenses\u003c\/strong\u003e. This metric tells you your safety cushion above covering overhead. For a high-fixed-cost operation like specialized heart care, you must target a ratio greater than \u003cstrong\u003e15x\u003c\/strong\u003e, reviewing this number monthly.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eQuickly assesses operational leverage safety margin.\u003c\/li\u003e\n\u003cli\u003eGuides decisions on adding fixed assets or staff.\u003c\/li\u003e\n\u003cli\u003eShows if revenue growth is outpacing overhead creep.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores the actual cash needed for CapEx.\u003c\/li\u003e\n\u003cli\u003eA high ratio might mean you are understaffed.\u003c\/li\u003e\n\u003cli\u003eIt hides poor pricing if CM is inflated by high fees.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized medical centers relying on high-value procedures, benchmarks vary widely based on facility ownership structure. A target above \u003cstrong\u003e15x\u003c\/strong\u003e is aggressive, suggesting you have very few fixed costs relative to the high fees charged for TAH implantation and management. If your ratio falls below \u003cstrong\u003e5x\u003c\/strong\u003e, you are definitely running a high risk of insolvency if procedure volume dips.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIncrease surgeon utilization without hiring new fixed staff.\u003c\/li\u003e\n\u003cli\u003eRenegotiate long-term fixed contracts like facility leases.\u003c\/li\u003e\n\u003cli\u003eRaise service prices to boost the contribution margin per procedure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou find this ratio by dividing your total monthly contribution margin by your total monthly fixed operating expenses. This calculation requires you to clearly separate variable costs, like device consumables, from fixed costs, like administrative salaries.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nFixed Cost Coverage Ratio = Contribution Margin \/ Total Fixed Operating Expenses\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your specialized institute generates a \u003cstrong\u003eContribution Margin\u003c\/strong\u003e of \u003cstrong\u003e$2,250,000\u003c\/strong\u003e after accounting for variable costs associated with TAH procedures. If your \u003cstrong\u003eTotal Fixed Operating Expenses\u003c\/strong\u003e-salaries for non-surgical admin, rent, utilities-are \u003cstrong\u003e$150,000\u003c\/strong\u003e for the month, here is the math.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nFCCR = $2,250,000 \/ $150,000 = 15.0x\n\u003c\/div\u003e\n\u003cp\u003eIn this scenario, you hit the minimum target exactly. If CM rose to $2.4 million next month, the ratio would improve.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDefine fixed costs strictly; exclude variable sales commissions.\u003c\/li\u003e\n\u003cli\u003eTrack this ratio against Key Staff Capacity Utilization monthly.\u003c\/li\u003e\n\u003cli\u003eIf utilization is low, fixed costs are too high for current volume.\u003c\/li\u003e\n\u003cli\u003eIf the ratio dips below \u003cstrong\u003e12x\u003c\/strong\u003e, defintely review all non-clinical overhead spending.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 5\n: \u003cspan style=\"color: #126CFF;\"\u003eMonths to Payback\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eMonths to Payback shows you exactly how long it takes for your business cash flow to cover the initial big spending, the capital expenditure (CapEx). This metric is crucial because it measures the speed at which your investment becomes self-funding. For this specialized heart institute, the internal model targets a recovery time of \u003cstrong\u003e15 months\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eQuickly assesses investment viability against risk tolerance.\u003c\/li\u003e\n\u003cli\u003eHelps set realistic timelines for achieving positive cash flow.\u003c\/li\u003e\n\u003cli\u003eInforms decisions on scaling up or delaying further CapEx deployment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt's highly sensitive to initial CapEx estimates.\u003c\/li\u003e\n\u003cli\u003eIt ignores profitability metrics after the payback period ends.\u003c\/li\u003e\n\u003cli\u003eIt relies entirely on projected Free Cash Flow, which can shift.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIn specialized medical fields requiring heavy initial investment in unique surgical technology, payback periods often stretch longer than in standard service businesses. While \u003cstrong\u003e15 months\u003c\/strong\u003e is an aggressive goal, anything over 30 months signals serious capital drag. You must compare this against the expected lifespan of the core technology you are buying.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIncrease procedure volume per surgeon to drive revenue faster.\u003c\/li\u003e\n\u003cli\u003eAggressively manage working capital to improve monthly cash flow.\u003c\/li\u003e\n\u003cli\u003eChallenge initial CapEx assumptions; can leasing reduce upfront cost?\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo find this time, you take the total amount spent on long-term assets and divide it by the average monthly cash flow you expect to generate after paying all operating costs. This calculation shows the recovery timeline for your initial outlay.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nMonths to Payback = Total CapEx \/ Average Monthly Free Cash Flow\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your total initial investment for the specialized center, including the TAH devices and facility build-out, is estimated at \u003cstrong\u003e$15 million\u003c\/strong\u003e. To hit the \u003cstrong\u003e15-month\u003c\/strong\u003e target, your model must project that the business generates \u003cstrong\u003e$1 million\u003c\/strong\u003e in Free Cash Flow every month.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nMonths to Payback = $15,000,000 \/ $1,000,000 per month = 15 Months\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this metric quarterly, as specified in the plan.\u003c\/li\u003e\n\u003cli\u003eEnsure CapEx includes all soft costs like initial training and certification.\u003c\/li\u003e\n\u003cli\u003eIf utilization rates drop, the payback period will defintely extend.\u003c\/li\u003e\n\u003cli\u003eTrack the components driving Free Cash Flow, like the Gross Margi\nn Percentage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 6\n: \u003cspan style=\"color: #126CFF;\"\u003eTAH Device Cost Percentage\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe \u003cstrong\u003eTAH Device Cost Percentage\u003c\/strong\u003e shows what share of your total revenue goes just to buying the Total Artificial Heart devices. This metric tracks your single largest variable expense, which is crucial because these devices are incredibly expensive. If this number is too high, your ability to cover fixed costs and make money disappears fast.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eImmediately flags when device procurement costs spike unexpectedly.\u003c\/li\u003e\n\u003cli\u003eDrives focused negotiation strategy with the device supplier.\u003c\/li\u003e\n\u003cli\u003eHelps forecast future profitability based on device price stability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt doesn't account for the cost of specialized consumables used during surgery.\u003c\/li\u003e\n\u003cli\u003eA low percentage might hide poor revenue capture if procedures are underbilled.\u003c\/li\u003e\n\u003cli\u003eIt's highly sensitive to the timing of large, infrequent device purchases.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized medical centers like yours, general industry benchmarks don't really apply; this metric is almost entirely internal. Your target trajectory-starting at \u003cstrong\u003e120%\u003c\/strong\u003e in 2026 and aiming for \u003cstrong\u003e100%\u003c\/strong\u003e by 2030-is your benchmark. This implies that initially, the cost of the device exceeds the revenue recognized for the procedure, which is a tough spot that needs aggressive management.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSecure multi-year volume commitments to lock in lower unit pricing.\u003c\/li\u003e\n\u003cli\u003eImprove surgeon throughput (KPI 1) to spread fixed device costs over more billable procedures.\u003c\/li\u003e\n\u003cli\u003eReview reimbursement coding quarterly to ensure maximum revenue capture per implant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this by taking the total cost paid for all TAH devices during the period and dividing it by the total revenue generated from all related services that period. This is a key metric for understanding your baseline cost structure.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nTAH Device Cost Percentage = (Total TAH Device Cost \/ Total Revenue) x 100\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eLet's look at your 2026 target scenario. Say your center performs enough procedures to generate \u003cstrong\u003e$10 million\u003c\/strong\u003e in Total Revenue for the year. To hit the \u003cstrong\u003e120%\u003c\/strong\u003e target, the cost of the devices purchased must equal 120% of that revenue.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nTAH Device Cost Percentage = ($12,000,000 TAH Device Cost \/ $10,000,000 Total Revenue) x 100 = \u003cstrong\u003e120%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf the device cost was only $9 million, the percentage would be 90%, meaning you'd be ahead of schedule for 2030. Honestly, getting this below 100% is where you start making real money.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this metric defintely on a quarterly basis as planned.\u003c\/li\u003e\n\u003cli\u003eIsolate device costs from general surgical supply costs immediately.\u003c\/li\u003e\n\u003cli\u003eTrack the cost per unit against the average reimbursement rate per procedure.\u003c\/li\u003e\n\u003cli\u003eIf the percentage rises above 120% in any quarter, flag it for immediate executive review.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 7\n: \u003cspan style=\"color: #126CFF;\"\u003eReturn on Equity (ROE)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eReturn on Equity (ROE) shows how well the business uses the money owners put in to make a profit. It's the main gauge of management effectiveness regarding shareholder capital. For this specialized heart institute, the model projects a massive \u003cstrong\u003e18126%\u003c\/strong\u003e ROE.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows true efficiency of owner capital deployment.\u003c\/li\u003e\n\u003cli\u003eDrives focus toward high-margin surgical procedures.\u003c\/li\u003e\n\u003cli\u003eSignals strong profitability to potential future investors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCan be skewed by high levels of debt financing.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for operational risk exposure in complex surgery.\u003c\/li\u003e\n\u003cli\u003eHigh ROE might hide poor working capital management.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor established, stable healthcare providers, a healthy ROE often sits above \u003cstrong\u003e15%\u003c\/strong\u003e. However, for high-growth, capital-intensive centers like this one, targets are much higher, like the \u003cstrong\u003e\u0026gt;100%\u003c\/strong\u003e goal set here. This metric tells investors if the specialized TAH center is generating outsized returns on their invested capital.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBoost Net Income by maximizing practitioner utilization.\u003c\/li\u003e\n\u003cli\u003eMinimize shareholder equity through strategic debt financing.\u003c\/li\u003e\n\u003cli\u003eAggressively manage operating expenses to increase the numerator.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate ROE by dividing the company's Net Income by the total Shareholder Equity. This shows the return generated for every dollar of equity capital invested in the business.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nReturn on Equity = Net Income \/ Shareholder Equity\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo see what the projected \u003cstrong\u003e18126%\u003c\/strong\u003e ROE means operationally, let's use a hypothetical equity base. If the institute has \u003cstrong\u003e$1,000,000\u003c\/strong\u003e in Shareholder Equity, the projected Net Income required to hit that target must be \u003cstrong\u003e$181,260\u003c\/strong\u003e. This demonstrates the high level of profit generation expected relative to owner investment.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n18126% = $181,260 (Net Income) \/ $1,000,000 (Shareholder Equity)\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this figure only \u003cstrong\u003eannually\u003c\/strong\u003e for long-term strategic planning.\u003c\/li\u003e\n\u003cli\u003eWatch for spikes caused by one-time asset sales or financing events.\u003c\/li\u003e\n\u003cli\u003eEnsure the equity base accurately reflects true invested capital.\u003c\/li\u003e\n\u003cli\u003eIf equity shrinks due to buybacks, ROE will artificially inflate; watch that defintely.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304460591347,"sku":"total-artificial-heart-kpi-metrics","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/total-artificial-heart-kpi-metrics.webp?v=1782694030","url":"https:\/\/financialmodelslab.com\/products\/total-artificial-heart-kpi-metrics","provider":"Financial Models Lab","version":"1.0","type":"link"}